Chemical Space Exploration

Chemical Space Exploration

Chemical Space exploration comes in different shapes and colors and can be roughly divided into two camps: the construction of Chemical Spaces and the directed search within those. The aim of the first is to build up a collection of molecules or chemical entities that either exhausts all possibilities or covers a focused part of the total. Once generated, Chemical Spaces can be searched for molecules with specific properties that comply with the needs of the projects (e.g., drug discovery, chemical catalysts, cosmetics, etc.).
We have collected some aspects and examples of the Chemical Space exploration with applications from drug discovery and medicinal chemistry.

Accelerated Structure-Activity Relationship Elucidation

Klingler et al. introduced the concept of "SAR by Space" (SAR = structure-activity relationship; you may have heard of "SAR by NMR" by Abbott, or "SAR by Catalog" by Astex). This method aims to accelerate early stages of drug discovery by utilizing the accessibility of compounds from vendors. The premise is simple: Starting with a query molecule, scientists can search in vast make-on-demand Chemical Spaces for related compounds and analogs. Molecules of interest can be ordered and synthesized within weeks.
This approach has several perks: Companies without in-house facilities can cost-efficiently advance their projects in a short period of time. Furthermore, the increasing number of commercial Chemical Spaces increases diversity and possibilities to find interesting follow-ups.

Ring systems and their bioisosteric replacements

Peter Ertl extracted bioactive ring systems and their respective targets from a billion of drug-like molecules resulting in the creation of a ring Chemical Space with almost 40,000 molecular scaffolds.
Rings represent privileged motives in medicinal chemistry as they define the shape of the molecule, are responsible for the orientation of attached groups and often contribute to the binding affinity on their own. Yet sometimes ring replacement (also described as scaffold replacement) is required due to promiscuity of the system, unfavored physicochemical properties, toxicity issues, or intellectual property claims.

BioSolveIT software tackles this problem with the scaffold replacement tool ReCore and infiniSee that performs fuzzy pharmacophore search for distant neighbors to a query molecule.
The interactive browser application from the publication can be accessed here.
Navigation in the Ring Chemical Space Guided by the Bioactive Rings.
Ertl, P.
J. Chem. Inf. Model. 2021.

Enumeration of accessible molecules

The Reymond group from the University of Bern in Switzerland made their efforts to enumerate small organic molecules leading to the GDB databases. The numbering of the data sets specifies how many heavy atoms were used for the construction of the Chemical Space. Users can use the sets for virtual screening (e.g. with SeeSAR or FlexX) to search for synthetically accessible compounds.
Enumerated data sets require a vast amount of storage to be processed. Hits from combinatorial spaces on the other hand are built up during the search, thus lowering the computational requirements.
"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Webinars
A Novel Class of SARS-CoV-2 Mpro Inhibitors: Systematic Design, Synthesis, Biological Evaluation, Antiviral Activity, and Structural Insights
Thu, 25 Apr 2024, 16:00 CEST (Berlin)
COVID-19 is shifting from pandemic to endemic, but the etiological agent, SARS-CoV-2, is still spreading and causing public health issues around the world. New variants, with multiple mutations in their spike proteins, are now able to evade neutralization by antibodies in vaccinated and convalescent individuals. Consequently, there is a pressing...
Read on

Be part of the Chemical Space community on LinkedIn!